ICAD INC. - COMMON STOCK

iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28

20 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow

19 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

05 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates

31 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography

15 Mar 2021 17:04:42 By Nasdaq GlobeNewswire

New Research Supporting ProFound AI Presented at European Congress of Radiology Online Meeting

08 Mar 2021 11:36:23 By Nasdaq GlobeNewswire

iCAD to Participate in the Cowen 41st Annual Health Care Conference

03 Mar 2021 20:16:22 By Nasdaq GlobeNewswire

iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock

02 Mar 2021 23:47:48 By Nasdaq GlobeNewswire

iCAD Announces Proposed Public Offering of Common Stock

02 Mar 2021 15:01:00 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2020

24 Feb 2021 15:01:01 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

18 Feb 2021 17:56:26 By Nasdaq GlobeNewswire

iCAD to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

16 Feb 2021 15:01:00 By Nasdaq GlobeNewswire

iCAD to Participate in B. Riley Securities Virtual Oncology Investor Conference

19 Jan 2021 07:00:02 By Nasdaq GlobeNewswire

iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

06 Jan 2021 15:01:00 By Nasdaq GlobeNewswire